---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-087594"
form_type: "8-K"
ticker: "MASS"
cik: "0001555279"
company_name: "908 Devices Inc."
filed_at: "2022-08-09T23:59:59+00:00"
generated_at: "2026-06-24T02:00:41.107766+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# 908 Devices reports Q2 revenue $11.1M (+34% YoY), reiterates FY22 guidance; acquires TRACE Analytics

## Summary
- Q2 revenue $11.1M, up 34% YoY; gross margin 60% vs 53% prior year.
- Net loss $8.1M ($0.26 loss per share) vs $7.4M ($0.27) prior year.
- Installed base 2,142 devices; placed 124 devices in Q2.
- FY2022 revenue guidance reaffirmed at $52M-$55M (23%-30% growth).
- Acquired TRACE Analytics, an online bioreactor sampling and biosensor technology provider.

## SEC filing metadata
- accession: 0001104659-22-087594
- form_type: 8-K
- ticker: MASS
- cik: 0001555279
- company_name: 908 Devices Inc.
- filed_at: 2022-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555279/000110465922087594/0001104659-22-087594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555279/000110465922087594/tm2222825d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-087594
- JSON: https://secwatch.observer/filing/0001104659-22-087594.json
- Plain text: https://secwatch.observer/filing/0001104659-22-087594.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.